Elequin Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17
| Closed | -$88 | – | 627 |
|
|
2024
Q3 | $88 | Buy |
+17
| New | +$88 | ﹤0.01% | 359 |
|
|
2024
Q2 | – | Sell |
-33
| Closed | -$162 | – | 381 |
|
|
2024
Q1 | $162 | Sell |
33
-29
| -47% | -$142 | ﹤0.01% | 225 |
|
|
2023
Q4 | $545 | Buy |
62
+46
| +288% | +$404 | ﹤0.01% | 321 |
|
|
2023
Q3 | $184 | Sell |
16
-248
| -94% | -$2.85K | ﹤0.01% | 365 |
|
|
2023
Q2 | $6.68K | Buy |
+264
| New | +$6.68K | ﹤0.01% | 341 |
|
|
2022
Q3 | – | Sell |
-50
| Closed | -$1K | – | 700 |
|
|
2022
Q2 | $1K | Sell |
50
-9
| -15% | -$180 | ﹤0.01% | 387 |
|
|
2022
Q1 | $1K | Buy |
+59
| New | +$1K | ﹤0.01% | 311 |
|